thalidomide has been researched along with Cheilitis in 2 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
Cheilitis: Inflammation of the lips. It is of various etiologies and degrees of pathology.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vega-Memije, ME | 1 |
| Mosqueda-Taylor, A | 1 |
| Irigoyen-Camacho, ME | 1 |
| Hojyo-Tomoka, MT | 1 |
| Domínguez-Soto, L | 1 |
| Thomas, P | 1 |
| Walchner, M | 1 |
| Ghoreschi, K | 1 |
| Röcken, M | 1 |
2 other studies available for thalidomide and Cheilitis
| Article | Year |
|---|---|
Actinic prurigo cheilitis: clinicopathologic analysis and therapeutic results in 116 cases.
Topics: Administration, Topical; Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Anti-Inflamma | 2002 |
Successful treatment of granulomatous cheilitis with thalidomide.
Topics: Administration, Oral; Adult; Biopsy, Needle; Cheilitis; Dose-Response Relationship, Drug; Drug Admin | 2003 |